In lung cancer, ROS1 fusion partners include FIG, CD74, SLC34A2 and SDC4, which lead to oncogenic transformation and constitutive kinase activity in cell culture and/or in vivo [8, 11, 12]. Here, ROS1 is linked to lung cancer.